Elekta to Sponsor Brachytherapy Mini-Series on The Balancing Act® airing on Lifetime Television
Physicians will educate viewers on brachytherapy as treatment option for many types of cancer
(Pompano Beach, FL – PR.Com/CISION –February 28, 2014) – Popular show The Balancing Act® airing on Lifetime TV welcomes Elekta – innovators in clinical solutions for treating cancer –as sponsors of the show for a three-part miniseries on brachytherapy. Experts in brachytherapy will be making their appearance as part of a “Health Matter” series beginning in April 2014.
Brachytherapy is a form of radiation therapy that treats from the “inside-out.” The three-part series will cover these topics: “Understanding Endorectal Cancer & Treatment Options,” “Understanding Melanoma & Treatment Options,” and “Gynecological Cancers & Treatment Options.” Experts will educate viewers, namely patients and caregivers, on brachytherapy as a treatment option.
To learn more about Elekta, please visit: www.elekta.com. To learn more about Brachytherapy, please visit www.aboutbrachytherapy.com
“We are proud to partner with Elekta for this miniseries, as cancer touches so many lives. It’s great that we can bring awareness to our viewers about treatment options they may not have known about,” said Carri Levy, Senior Associate Producer, The Balancing Act.
About The Balancing Act® on Lifetime Television
Now in its 6th year, The Balancing Act® continues to empower women in all aspects of their lives. The mission at The Balancing Act® is simple -- the show strives to help today’s modern woman balance it all by bringing them exceptional solutions to everyday problems. Entertaining, educational and trusted by women, viewers can watch America’s premier morning show The Balancing Act® weekday mornings on Lifetime television at 7 am (ET/PT).
For additional information or to view a segment visit: www.thebalancingact.com
Join the Conversation!
Like us on Facebook
Follow us on Twitter
Watch us on YouTube
Media Contact:
O2 Media, Inc.
pamela@o2mediainc.com
(954) 691-1102
Tags: